 | • レポートコード：MRC2-11QY11241 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は犬幹細胞治療のグローバル市場について調査・分析したレポートです。種類別（同種幹細胞、自家幹細胞）市場規模、用途別（獣医病院、獣医クリニック、獣医研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別犬幹細胞治療の競争状況、市場シェア ・世界の犬幹細胞治療市場：種類別市場規模 2015年-2020年（同種幹細胞、自家幹細胞） ・世界の犬幹細胞治療市場：種類別市場規模予測 2021年-2026年（同種幹細胞、自家幹細胞） ・世界の犬幹細胞治療市場：用途別市場規模 2015年-2020年（獣医病院、獣医クリニック、獣医研究所） ・世界の犬幹細胞治療市場：用途別市場規模予測 2021年-2026年（獣医病院、獣医クリニック、獣医研究所） ・北米の犬幹細胞治療市場分析：米国、カナダ ・ヨーロッパの犬幹細胞治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの犬幹細胞治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の犬幹細胞治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの犬幹細胞治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：VETSTEM BIOPHARMA、Cell Therapy Sciences、Regeneus、Aratana Therapeutics、Medivet Biologics、Okyanos、Vetbiologics、VetMatrix、Magellan Stem Cells、ANIMAL CELL THERAPIES、Stemcellvet ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.
A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry.
Market Analysis and Insights: Global Canine Stem Cell Therapy Market
The global Canine Stem Cell Therapy market size is projected to reach US$ 103.4 million by 2026, from US$ 100.7 million in 2020, at a CAGR of 2.4%% during 2021-2026.
Global Canine Stem Cell Therapy Scope and Market Size
Canine Stem Cell Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Canine Stem Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
VETSTEM BIOPHARMA
Cell Therapy Sciences
Regeneus
Aratana Therapeutics
Medivet Biologics
Okyanos
Vetbiologics
VetMatrix
Magellan Stem Cells
ANIMAL CELL THERAPIES
Stemcellvet
Market segment by Type, the product can be split into
Allogeneic Stem Cells
Autologous Stem cells
Market segment by Application, split into
Veterinary Hospitals
Veterinary Clinics
Veterinary Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Canine Stem Cell Therapy Revenue
1.4 Market by Type
1.4.1 Global Canine Stem Cell Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Allogeneic Stem Cells
1.4.3 Autologous Stem cells
1.5 Market by Application
1.5.1 Global Canine Stem Cell Therapy Market Share by Application: 2020 VS 2026
1.5.2 Veterinary Hospitals
1.5.3 Veterinary Clinics
1.5.4 Veterinary Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Canine Stem Cell Therapy Market Perspective (2015-2026)
2.2 Global Canine Stem Cell Therapy Growth Trends by Regions
2.2.1 Canine Stem Cell Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Canine Stem Cell Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Canine Stem Cell Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Canine Stem Cell Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Canine Stem Cell Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Canine Stem Cell Therapy Players by Market Size
3.1.1 Global Top Canine Stem Cell Therapy Players by Revenue (2015-2020)
3.1.2 Global Canine Stem Cell Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Canine Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Canine Stem Cell Therapy Market Concentration Ratio
3.2.1 Global Canine Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Canine Stem Cell Therapy Revenue in 2019
3.3 Canine Stem Cell Therapy Key Players Head office and Area Served
3.4 Key Players Canine Stem Cell Therapy Product Solution and Service
3.5 Date of Enter into Canine Stem Cell Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Canine Stem Cell Therapy Historic Market Size by Type (2015-2020)
4.2 Global Canine Stem Cell Therapy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Canine Stem Cell Therapy Market Size by Application (2015-2020)
5.2 Global Canine Stem Cell Therapy Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Canine Stem Cell Therapy Market Size (2015-2020)
6.2 Canine Stem Cell Therapy Key Players in North America (2019-2020)
6.3 North America Canine Stem Cell Therapy Market Size by Type (2015-2020)
6.4 North America Canine Stem Cell Therapy Market Size by Application (2015-2020)
7 Europe
7.1 Europe Canine Stem Cell Therapy Market Size (2015-2020)
7.2 Canine Stem Cell Therapy Key Players in Europe (2019-2020)
7.3 Europe Canine Stem Cell Therapy Market Size by Type (2015-2020)
7.4 Europe Canine Stem Cell Therapy Market Size by Application (2015-2020)
8 China
8.1 China Canine Stem Cell Therapy Market Size (2015-2020)
8.2 Canine Stem Cell Therapy Key Players in China (2019-2020)
8.3 China Canine Stem Cell Therapy Market Size by Type (2015-2020)
8.4 China Canine Stem Cell Therapy Market Size by Application (2015-2020)
9 Japan
9.1 Japan Canine Stem Cell Therapy Market Size (2015-2020)
9.2 Canine Stem Cell Therapy Key Players in Japan (2019-2020)
9.3 Japan Canine Stem Cell Therapy Market Size by Type (2015-2020)
9.4 Japan Canine Stem Cell Therapy Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Canine Stem Cell Therapy Market Size (2015-2020)
10.2 Canine Stem Cell Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Canine Stem Cell Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Canine Stem Cell Therapy Market Size by Application (2015-2020)
11 India
11.1 India Canine Stem Cell Therapy Market Size (2015-2020)
11.2 Canine Stem Cell Therapy Key Players in India (2019-2020)
11.3 India Canine Stem Cell Therapy Market Size by Type (2015-2020)
11.4 India Canine Stem Cell Therapy Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Canine Stem Cell Therapy Market Size (2015-2020)
12.2 Canine Stem Cell Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Canine Stem Cell Therapy Market Size by Type (2015-2020)
12.4 Central & South America Canine Stem Cell Therapy Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 VETSTEM BIOPHARMA
13.1.1 VETSTEM BIOPHARMA Company Details
13.1.2 VETSTEM BIOPHARMA Business Overview
13.1.3 VETSTEM BIOPHARMA Canine Stem Cell Therapy Introduction
13.1.4 VETSTEM BIOPHARMA Revenue in Canine Stem Cell Therapy Business (2015-2020))
13.1.5 VETSTEM BIOPHARMA Recent Development
13.2 Cell Therapy Sciences
13.2.1 Cell Therapy Sciences Company Details
13.2.2 Cell Therapy Sciences Business Overview
13.2.3 Cell Therapy Sciences Canine Stem Cell Therapy Introduction
13.2.4 Cell Therapy Sciences Revenue in Canine Stem Cell Therapy Business (2015-2020)
13.2.5 Cell Therapy Sciences Recent Development
13.3 Regeneus
13.3.1 Regeneus Company Details
13.3.2 Regeneus Business Overview
13.3.3 Regeneus Canine Stem Cell Therapy Introduction
13.3.4 Regeneus Revenue in Canine Stem Cell Therapy Business (2015-2020)
13.3.5 Regeneus Recent Development
13.4 Aratana Therapeutics
13.4.1 Aratana Therapeutics Company Details
13.4.2 Aratana Therapeutics Business Overview
13.4.3 Aratana Therapeutics Canine Stem Cell Therapy Introduction
13.4.4 Aratana Therapeutics Revenue in Canine Stem Cell Therapy Business (2015-2020)
13.4.5 Aratana Therapeutics Recent Development
13.5 Medivet Biologics
13.5.1 Medivet Biologics Company Details
13.5.2 Medivet Biologics Business Overview
13.5.3 Medivet Biologics Canine Stem Cell Therapy Introduction
13.5.4 Medivet Biologics Revenue in Canine Stem Cell Therapy Business (2015-2020)
13.5.5 Medivet Biologics Recent Development
13.6 Okyanos
13.6.1 Okyanos Company Details
13.6.2 Okyanos Business Overview
13.6.3 Okyanos Canine Stem Cell Therapy Introduction
13.6.4 Okyanos Revenue in Canine Stem Cell Therapy Business (2015-2020)
13.6.5 Okyanos Recent Development
13.7 Vetbiologics
13.7.1 Vetbiologics Company Details
13.7.2 Vetbiologics Business Overview
13.7.3 Vetbiologics Canine Stem Cell Therapy Introduction
13.7.4 Vetbiologics Revenue in Canine Stem Cell Therapy Business (2015-2020)
13.7.5 Vetbiologics Recent Development
13.8 VetMatrix
13.8.1 VetMatrix Company Details
13.8.2 VetMatrix Business Overview
13.8.3 VetMatrix Canine Stem Cell Therapy Introduction
13.8.4 VetMatrix Revenue in Canine Stem Cell Therapy Business (2015-2020)
13.8.5 VetMatrix Recent Development
13.9 Magellan Stem Cells
13.9.1 Magellan Stem Cells Company Details
13.9.2 Magellan Stem Cells Business Overview
13.9.3 Magellan Stem Cells Canine Stem Cell Therapy Introduction
13.9.4 Magellan Stem Cells Revenue in Canine Stem Cell Therapy Business (2015-2020)
13.9.5 Magellan Stem Cells Recent Development
13.10 ANIMAL CELL THERAPIES
13.10.1 ANIMAL CELL THERAPIES Company Details
13.10.2 ANIMAL CELL THERAPIES Business Overview
13.10.3 ANIMAL CELL THERAPIES Canine Stem Cell Therapy Introduction
13.10.4 ANIMAL CELL THERAPIES Revenue in Canine Stem Cell Therapy Business (2015-2020)
13.10.5 ANIMAL CELL THERAPIES Recent Development
13.11 Stemcellvet
10.11.1 Stemcellvet Company Details
10.11.2 Stemcellvet Business Overview
10.11.3 Stemcellvet Canine Stem Cell Therapy Introduction
10.11.4 Stemcellvet Revenue in Canine Stem Cell Therapy Business (2015-2020)
10.11.5 Stemcellvet Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Canine Stem Cell Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Canine Stem Cell Therapy Revenue
Table 3. Ranking of Global Top Canine Stem Cell Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Canine Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Allogeneic Stem Cells
Table 6. Key Players of Autologous Stem cells
Table 7. Global Canine Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Canine Stem Cell Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Canine Stem Cell Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Canine Stem Cell Therapy Market Share by Regions (2015-2020)
Table 11. Global Canine Stem Cell Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Canine Stem Cell Therapy Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Canine Stem Cell Therapy Market Growth Strategy
Table 17. Main Points Interviewed from Key Canine Stem Cell Therapy Players
Table 18. Global Canine Stem Cell Therapy Revenue by Players (2015-2020) (Million US$)
Table 19. Global Canine Stem Cell Therapy Market Share by Players (2015-2020)
Table 20. Global Top Canine Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canine Stem Cell Therapy as of 2019)
Table 21. Global Canine Stem Cell Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Canine Stem Cell Therapy Product Solution and Service
Table 24. Date of Enter into Canine Stem Cell Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Canine Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 27. Global Canine Stem Cell Therapy Market Size Share by Type (2015-2020)
Table 28. Global Canine Stem Cell Therapy Revenue Market Share by Type (2021-2026)
Table 29. Global Canine Stem Cell Therapy Market Size Share by Application (2015-2020)
Table 30. Global Canine Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 31. Global Canine Stem Cell Therapy Market Size Share by Application (2021-2026)
Table 32. North America Key Players Canine Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Canine Stem Cell Therapy Market Share (2019-2020)
Table 34. North America Canine Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 35. North America Canine Stem Cell Therapy Market Share by Type (2015-2020)
Table 36. North America Canine Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. North America Canine Stem Cell Therapy Market Share by Application (2015-2020)
Table 38. Europe Key Players Canine Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Canine Stem Cell Therapy Market Share (2019-2020)
Table 40. Europe Canine Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Canine Stem Cell Therapy Market Share by Type (2015-2020)
Table 42. Europe Canine Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Canine Stem Cell Therapy Market Share by Application (2015-2020)
Table 44. China Key Players Canine Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 45. China Key Players Canine Stem Cell Therapy Market Share (2019-2020)
Table 46. China Canine Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. China Canine Stem Cell Therapy Market Share by Type (2015-2020)
Table 48. China Canine Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. China Canine Stem Cell Therapy Market Share by Application (2015-2020)
Table 50. Japan Key Players Canine Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Canine Stem Cell Therapy Market Share (2019-2020)
Table 52. Japan Canine Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Canine Stem Cell Therapy Market Share by Type (2015-2020)
Table 54. Japan Canine Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Canine Stem Cell Therapy Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Canine Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Canine Stem Cell Therapy Market Share (2019-2020)
Table 58. Southeast Asia Canine Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Canine Stem Cell Therapy Market Share by Type (2015-2020)
Table 60. Southeast Asia Canine Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Canine Stem Cell Therapy Market Share by Application (2015-2020)
Table 62. India Key Players Canine Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 63. India Key Players Canine Stem Cell Therapy Market Share (2019-2020)
Table 64. India Canine Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. India Canine Stem Cell Therapy Market Share by Type (2015-2020)
Table 66. India Canine Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. India Canine Stem Cell Therapy Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Canine Stem Cell Therapy Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Canine Stem Cell Therapy Market Share (2019-2020)
Table 70. Central & South America Canine Stem Cell Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Canine Stem Cell Therapy Market Share by Type (2015-2020)
Table 72. Central & South America Canine Stem Cell Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Canine Stem Cell Therapy Market Share by Application (2015-2020)
Table 74. VETSTEM BIOPHARMA Company Details
Table 75. VETSTEM BIOPHARMA Business Overview
Table 76. VETSTEM BIOPHARMA Product
Table 77. VETSTEM BIOPHARMA Revenue in Canine Stem Cell Therapy Business (2015-2020) (Million US$)
Table 78. VETSTEM BIOPHARMA Recent Development
Table 79. Cell Therapy Sciences Company Details
Table 80. Cell Therapy Sciences Business Overview
Table 81. Cell Therapy Sciences Product
Table 82. Cell Therapy Sciences Revenue in Canine Stem Cell Therapy Business (2015-2020) (Million US$)
Table 83. Cell Therapy Sciences Recent Development
Table 84. Regeneus Company Details
Table 85. Regeneus Business Overview
Table 86. Regeneus Product
Table 87. Regeneus Revenue in Canine Stem Cell Therapy Business (2015-2020) (Million US$)
Table 88. Regeneus Recent Development
Table 89. Aratana Therapeutics Company Details
Table 90. Aratana Therapeutics Business Overview
Table 91. Aratana Therapeutics Product
Table 92. Aratana Therapeutics Revenue in Canine Stem Cell Therapy Business (2015-2020) (Million US$)
Table 93. Aratana Therapeutics Recent Development
Table 94. Medivet Biologics Company Details
Table 95. Medivet Biologics Business Overview
Table 96. Medivet Biologics Product
Table 97. Medivet Biologics Revenue in Canine Stem Cell Therapy Business (2015-2020) (Million US$)
Table 98. Medivet Biologics Recent Development
Table 99. Okyanos Company Details
Table 100. Okyanos Business Overview
Table 101. Okyanos Product
Table 102. Okyanos Revenue in Canine Stem Cell Therapy Business (2015-2020) (Million US$)
Table 103. Okyanos Recent Development
Table 104. Vetbiologics Company Details
Table 105. Vetbiologics Business Overview
Table 106. Vetbiologics Product
Table 107. Vetbiologics Revenue in Canine Stem Cell Therapy Business (2015-2020) (Million US$)
Table 108. Vetbiologics Recent Development
Table 109. VetMatrix Business Overview
Table 110. VetMatrix Product
Table 111. VetMatrix Company Details
Table 112. VetMatrix Revenue in Canine Stem Cell Therapy Business (2015-2020) (Million US$)
Table 113. VetMatrix Recent Development
Table 114. Magellan Stem Cells Company Details
Table 115. Magellan Stem Cells Business Overview
Table 116. Magellan Stem Cells Product
Table 117. Magellan Stem Cells Revenue in Canine Stem Cell Therapy Business (2015-2020) (Million US$)
Table 118. Magellan Stem Cells Recent Development
Table 119. ANIMAL CELL THERAPIES Company Details
Table 120. ANIMAL CELL THERAPIES Business Overview
Table 121. ANIMAL CELL THERAPIES Product
Table 122. ANIMAL CELL THERAPIES Revenue in Canine Stem Cell Therapy Business (2015-2020) (Million US$)
Table 123. ANIMAL CELL THERAPIES Recent Development
Table 124. Stemcellvet Company Details
Table 125. Stemcellvet Business Overview
Table 126. Stemcellvet Product
Table 127. Stemcellvet Revenue in Canine Stem Cell Therapy Business (2015-2020) (Million US$)
Table 128. Stemcellvet Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Canine Stem Cell Therapy Market Share by Type: 2020 VS 2026
Figure 2. Allogeneic Stem Cells Features
Figure 3. Autologous Stem cells Features
Figure 4. Global Canine Stem Cell Therapy Market Share by Application: 2020 VS 2026
Figure 5. Veterinary Hospitals Case Studies
Figure 6. Veterinary Clinics Case Studies
Figure 7. Veterinary Research Institutes Case Studies
Figure 8. Canine Stem Cell Therapy Report Years Considered
Figure 9. Global Canine Stem Cell Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Canine Stem Cell Therapy Market Share by Regions: 2020 VS 2026
Figure 11. Global Canine Stem Cell Therapy Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Canine Stem Cell Therapy Market Share by Players in 2019
Figure 14. Global Top Canine Stem Cell Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canine Stem Cell Therapy as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Canine Stem Cell Therapy Revenue in 2019
Figure 16. North America Canine Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Canine Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Canine Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Canine Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Canine Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Canine Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Canine Stem Cell Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
がん幹細胞治療の世界市場（～2026年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Stem Cell Therapy Scope and Market Size Cancer Stem Cell T…- 変形性関節症における幹細胞治療の世界市場（～2026年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…
- 自家幹細胞ベース治療法の世界市場（～2026年） Market Analysis and Insights: Global Autologous Stem Cell Based Therapies Market The global Autologous Stem Cell Based Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Autologous Stem Cell Based Therapies Scop…
- 多発性硬化症における幹細胞治療の世界市場（～2026年） Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…
- 糖尿病・関連疾患用幹細胞療法の世界市場（～2026年） Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2). NSI-566 is the stem cell thera…